Literature DB >> 10082540

New insights into the mechanism of inhibition of p53 by simian virus 40 large T antigen.

H M Sheppard1, S I Corneillie, C Espiritu, A Gatti, X Liu.   

Abstract

Simian virus 40 (SV40) large tumor antigen (T antigen) has been shown to inhibit p53-dependent transcription by preventing p53 from binding to its cognate cis element. Data presented in this report provide the first direct functional evidence that T antigen, under certain conditions, may also repress p53-dependent transcription by a mechanism in which the transactivation domain of p53 is abrogated while DNA binding is unaffected. Specifically, p53 purified as a complex with T antigen from mouse cells was found to bind DNA as a transcriptionally inactive intact complex, while that purified from human cells was found to bind DNA independently of T antigen and could activate p53-dependent transcription. This difference in activity may be dependent on a different interaction of T antigen with mouse and human p53 and, in addition, on the presence of super T, which is found only in transformed rodent cells. These results suggest that subtle yet important differences exist between the inhibition of p53 by T antigen in mouse and human cells. The implications of this finding with respect to SV40-associated malignancies are discussed.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10082540      PMCID: PMC84067          DOI: 10.1128/MCB.19.4.2746

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  42 in total

1.  Origin binding by a 100,000-dalton super-T antigen from SVT2 cells.

Authors:  V G Wilson; R L Williams
Journal:  J Virol       Date:  1985-10       Impact factor: 5.103

2.  Small peptides activate the latent sequence-specific DNA binding function of p53.

Authors:  T R Hupp; A Sparks; D P Lane
Journal:  Cell       Date:  1995-10-20       Impact factor: 41.582

3.  Structure and synthesis of a simian virus 40 super T-antigen.

Authors:  M Lovett; C E Clayton; D Murphy; P W Rigby; A E Smith; F Chaudry
Journal:  J Virol       Date:  1982-12       Impact factor: 5.103

4.  Fluctuation of simian virus 40 (SV40) super T-antigen expression in tumors induced by SV40-transformed mouse mammary epithelial cells.

Authors:  J S Butel; C Wong; B K Evans
Journal:  J Virol       Date:  1986-11       Impact factor: 5.103

5.  Two integrated partial repeats of simian virus 40 together code for a super-T antigen.

Authors:  A Levitt; S Chen; G Blanck; D George; R E Pollack
Journal:  Mol Cell Biol       Date:  1985-04       Impact factor: 4.272

6.  Characterization of different tumor antigens present in cells transformed by simian virus 40.

Authors:  A E Smith; R Smith; E Paucha
Journal:  Cell       Date:  1979-10       Impact factor: 41.582

7.  Accurate transcription initiation by RNA polymerase II in a soluble extract from isolated mammalian nuclei.

Authors:  J D Dignam; R M Lebovitz; R G Roeder
Journal:  Nucleic Acids Res       Date:  1983-03-11       Impact factor: 16.971

8.  Nonlytic simian virus 40-specific 100K phosphoprotein is associated with anchorage-independent growth in simian virus 40-transformed and revertant mouse cell lines.

Authors:  S Chen; M Verderame; A Lo; R Pollack
Journal:  Mol Cell Biol       Date:  1981-11       Impact factor: 4.272

9.  Mapping of the viral mRNA encoding a super-T antigen of 115,000 daltons expressed in simian virus 40-transformed rat cell lines.

Authors:  E May; M Kress; L Daya-Grosjean; R Monier; P May
Journal:  J Virol       Date:  1981-01       Impact factor: 5.103

10.  Reversal of in vitro p53 squelching by both TFIIB and TFIID.

Authors:  X Liu; A J Berk
Journal:  Mol Cell Biol       Date:  1995-11       Impact factor: 4.272

View more
  23 in total

1.  Stimulation of p53 DNA binding by c-Abl requires the p53 C terminus and tetramerization.

Authors:  Y Nie; H H Li; C M Bula; X Liu
Journal:  Mol Cell Biol       Date:  2000-02       Impact factor: 4.272

2.  p53 Stimulates TFIID-TFIIA-promoter complex assembly, and p53-T antigen complex inhibits TATA binding protein-TATA interaction.

Authors:  J Xing; H M Sheppard; S I Corneillie; X Liu
Journal:  Mol Cell Biol       Date:  2001-06       Impact factor: 4.272

3.  Quantitative Proteomic Analysis of Enriched Nuclear Fractions from BK Polyomavirus-Infected Primary Renal Proximal Tubule Epithelial Cells.

Authors:  Joshua L Justice; Brandy Verhalen; Ranjit Kumar; Elliot J Lefkowitz; Michael J Imperiale; Mengxi Jiang
Journal:  J Proteome Res       Date:  2015-09-23       Impact factor: 4.466

4.  Immunodetection of SV40 T/t-antigens in human osteosrcoma in a series of Tunisian patients.

Authors:  S Ziadi; H Boughamoura; M Ben Maitig; R Ben Gacem; S Mestiri; L Chaabani; M Trimeche
Journal:  Pathol Oncol Res       Date:  2012-07       Impact factor: 3.201

5.  The SV40 T antigen modulates CBP histone acetyltransferase activity.

Authors:  Ester Valls; Xavier de la Cruz; Marian A Martínez-Balbás
Journal:  Nucleic Acids Res       Date:  2003-06-15       Impact factor: 16.971

6.  The BM2 protein of influenza B virus interacts with p53 and inhibits its transcriptional and apoptotic activities.

Authors:  H Zhang; H Yu; J Wang; M Zhang; X Wang; W Ahmad; M Duan; Z Guan
Journal:  Mol Cell Biochem       Date:  2015-02-11       Impact factor: 3.396

7.  The conserved core enzymatic activities and the distinct dynamics of polyomavirus large T antigens.

Authors:  Ping An; Jeffrey L Brodsky; James M Pipas
Journal:  Arch Biochem Biophys       Date:  2015-03-06       Impact factor: 4.013

8.  ARID1A, a factor that promotes formation of SWI/SNF-mediated chromatin remodeling, is a tumor suppressor in gynecologic cancers.

Authors:  Bin Guan; Tian-Li Wang; Ie-Ming Shih
Journal:  Cancer Res       Date:  2011-09-07       Impact factor: 12.701

9.  Copy number gain of hsa-miR-569 at 3q26.2 leads to loss of TP53INP1 and aggressiveness of epithelial cancers.

Authors:  Pradeep Chaluvally-Raghavan; Fan Zhang; Sunila Pradeep; Mark P Hamilton; Xi Zhao; Rajesha Rupaimoole; Tyler Moss; Yiling Lu; Shuangxing Yu; Chad V Pecot; Miriam R Aure; Sylvain Peuget; Cristian Rodriguez-Aguayo; Hee-Dong Han; Dong Zhang; Avinashnarayan Venkatanarayan; Marit Krohn; Vessela N Kristensen; Mihai Gagea; Prahlad Ram; Wenbin Liu; Gabriel Lopez-Berestein; Philip L Lorenzi; Anne-Lise Børresen-Dale; Koei Chin; Joe Gray; Nelson J Dusetti; Sean E McGuire; Elsa R Flores; Anil K Sood; Gordon B Mills
Journal:  Cancer Cell       Date:  2014-12-08       Impact factor: 31.743

10.  The Meq oncoprotein of Marek's disease virus interacts with p53 and inhibits its transcriptional and apoptotic activities.

Authors:  Xufang Deng; Xiangdong Li; Yang Shen; Yafeng Qiu; Zixue Shi; Donghua Shao; Yamei Jin; Hongjun Chen; Chan Ding; Li Li; Puyan Chen; Zhiyong Ma
Journal:  Virol J       Date:  2010-11-26       Impact factor: 4.099

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.